Kaken Pharmaceutical Co.
28-8, Honkomagome 2-chome, Bunkyo-ku,
Tokyo, 113-8650,
Japan
Tokyo, 113-8650,
Japan
81 3 5977-5001
Life Sciences
Kaken Pharmaceutical Co. Technographics
Kaken Pharmaceutical Co. Software Purchases and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Kaken Pharmaceutical Co. and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 1164 Kaken Pharmaceutical Co. employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Kaken Pharmaceutical Co. has purchased the following applications: SAP ERP ECC 6.0 for ERP Financial in 2012, Mynavi Crexta ATS for Applicant Tracking System in 2018, SAP ERP ECC 6.0 - Materials Management (MM) for Inventory Management in 2012 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Kaken Pharmaceutical Co. is running and its propensity to invest more and deepen its relationship with SAP , Mynavi Corporation , GlobalSign or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Kaken Pharmaceutical Co. revenues, which have grown to $572.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Kaken Pharmaceutical Co. intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Kaken Pharmaceutical Co. Data, Technology Stack, and Enterprise Applications
ERP Financial Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| SAP | Legacy | SAP ERP ECC 6.0 | ERP Financial | ERP Financial Management | B-EN-G | 2012 | 2012 |
In 2012, Kaken Pharmaceutical Co. implemented SAP ERP ECC 6.0 in the ERP Financial category through the KAIS project to establish an integrated management operation base and to respond to external changes such as IFRS and strengthened internal control. The initiative was driven by the need to unify payment and receipt operations and order processing while reducing dependency on individual system knowledge after operating host systems for over 30 years.
The SAP ERP ECC 6.0 deployment covered general accounting FI, management accounting CO, inventory and purchasing management MM, and sales management SD, with a clear execution policy to maximize standard SAP functions and pursue company-wide standardization and cost reduction. The implementation used B-EN-Gs pharmaceutical industry template B-EN-Gp to limit add-on development, and the organization reviewed and rebuilt output forms from scratch while routing nonessential internal reporting to a data warehouse for owner-issued analytics.
Integrations and operational coverage included linkage between SAP ERP ECC 6.0 and a data warehouse for reporting, and integration with workflow to strengthen internal control, with smoother data exchange to JD-NET reported after go-live. Operational consolidation was executed by centralizing order-receiving operations from eight nationwide branches to the head office, and by centralizing cash management and accounts receivable at the head office to enable real-time financial visibility.
Project governance emphasized a short implementation timeline, package adoption, and preparation for in-house maintenance, with B-EN-G serving as the implementation partner and planned phased handover of SAP operations to internal IT. The cutover occurred as scheduled in April 2012 to align with the fiscal year start, and add-ons to B-EN-Gp were intentionally limited to control cost and schedule while the company retained responsibility for developing and operating peripheral systems.
Post-implementation effects explicitly reported include smoother JD-NET data exchange, improved business process efficiency and speed, consolidation of purchase order flows across pharmaceuticals and agrochemicals, a shift from monthly to real-time accounts payable information, sales tabulation and analysis available at near next-day speed, and a 70 percent reduction in form volume after reviewing output forms.
|
HCM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Mynavi Corporation | Legacy | Mynavi Crexta ATS | Applicant Tracking System | HCM | n/a | 2018 | 2018 |
|
SCM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| SAP | Legacy | SAP ERP ECC 6.0 - Materials Management (MM) | Inventory Management | SCM | B-EN-G | 2012 | 2012 |
In 2012 Kaken Pharmaceutical Co. implemented SAP ERP ECC 6.0 - Materials Management (MM) under the KAIS project, adopting the B-EN-Gp pharmaceutical industry template to address legal compliance and strengthen internal control. The SAP ERP ECC 6.0 - Materials Management (MM) deployment was scoped alongside general accounting FI, management accounting CO, and sales SD, positioning Inventory Management as the central application category for purchasing and inventory control across the company.
The implementation emphasized maximizing standard SAP functionality and minimizing custom development, with B-EN-Gp used as the baseline and only a small number of add-on functions introduced. Materials Management configurations included unified purchase order flows for pharmaceuticals and agrochemicals, centralized procurement processing, and reengineered output forms, while transactional data was routed to an information analysis data warehouse to separate operational ERP processes from downstream reporting.
Integrations were explicitly limited to the ERP ecosystem, with ERP linked to workflow engines to strengthen internal control and with data exchange established to JD-NET and the company DWH for analytics. Operational coverage consolidated order receiving from eight branches nationwide into the head office, and treasury and accounts receivable processes were centralized to enable near real-time visibility of financial information through the SAP solution.
Governance and rollout followed a policy of standardization, cost reduction, and preparation for in-house maintenance, with B-EN-G acting as system integrator and a planned handover of operations to Kaken over time. The project cut over as planned in April 2012 when the fiscal year switched, was completed on schedule and at low cost, and produced explicit operational outcomes including a 70% reduction in forms, accelerated sales reporting to near next day tabulation, and a shift from monthly to real-time accounts payable visibility.
|
|
|
|
|
Supply Chain Management | SCM |
|
2012 | 2012 |
|
CyberSecurity
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Secure Sockets Layer (SSL) | CyberSecurity |
|
2020 | 2020 |
|
IT Decision Makers and Key Stakeholders at Kaken Pharmaceutical Co.
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by Kaken Pharmaceutical Co. Executives
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||
FAQ - APPS RUN THE WORLD Kaken Pharmaceutical Co. Technographics
Kaken Pharmaceutical Co. is a Life Sciences organization based in Japan,
with around 1164 employees and annual revenues of $572.0 million.
Kaken Pharmaceutical Co. operates a diverse technology stack with applications such as
SAP ERP ECC 6.0, Mynavi Crexta ATS and SAP ERP ECC 6.0 - Materials Management (MM),
covering areas like ERP Financial, Applicant Tracking System and Inventory Management.
Kaken Pharmaceutical Co. has invested in cloud applications and AI-driven platforms to optimize efficiency and growth,
collaborating with vendors such as SAP and Mynavi Corporation.
Kaken Pharmaceutical Co. recently adopted applications including
GlobalSign SSL RSA in 2020, Mynavi Crexta ATS in 2018 and SAP ERP ECC 6.0 in 2012,
highlighting its ongoing modernization strategy.
APPS RUN THE WORLD maintains an up-to-date database of Kaken Pharmaceutical Co.’s key decision makers and IT executives,
available to Premium subscribers.
Our research team continuously updates Kaken Pharmaceutical Co.’s profile with verified software purchases,
vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete Kaken Pharmaceutical Co. technographics profile,
including detailed breakdowns by category, vendor, and IT decision makers.